Skip to main content
Conferences and Meetings 621. Lymphomas: Translational Molecular and Genetic: Poster III

621. Lymphomas: Translational Molecular and Genetic: Poster III

Short name: updated-621. Lymphomas: Translational Molecular and Genetic: Poster III-2025 Annual Meeting Poster Bundle Omics & Emerging Technologies
Course start date: 02/18/2026

Sections

General
0 activities

Novel mechanistic insights for IRAK1 and IRAK4 signaling provide a framework for the development of dual IRAK1 and IRAK4 protacs for MYD88 mutated lymphomas
Integration of longitudinal ctdna MRD and PET CT enhances prognostic stratification in newly diagnosed diffuse large B cell lymphoma A prospective multicenter study
Distinct genomic landscape response dynamics of HIV associated lymphomas identified by integrated noninvasive host and virome profiling
Comprehensive analysis of early ctdna kinetics following first cycle of R CHOP in LBCL patients
TP53 mutations in paired bone marrow and cell free DNA samples of patients with Waldenstroem macroglobulinemia or IgM monoclonal gammopathy of undetermined significance prospectively enrolled in the FIL biowm study of fondazione italiana li
Genomic characteristics of diffuse large B cell lymphoma associated with Wiskott Aldrich syndrome
Biomarker analysis to unravel mechanisms of resistance to glofitamab monotherapy in large B cell lymphoma
The prevalence of inborn errors of immunity IEI related gene germline variants and its prognostic impact in Chinese pediatric patients with lymphoma
Gene regulatory axes of diffuse large B cell lymphoma subtypes
Epitranscriptomic signatures define prognosis and therapeutic vulnerabilities in large B cell lymphoma
Dissecting the biology of hairy cell leukemia variant Insights from whole exome and RNA sequencing
Deciphering tph cells as prognostic drivers of angioimmunoblastic T cell lymphoma
An immune desert phenotype underlies therapy resistance in LBCL through distinct microenvironment related miRNA profiles
DNMT3B functions as tumor suppressor in mantle cell lymphoma
Performance of molecular classifiers relative to the international prognostic index IPI for overall and event free survival in diffuse large B cell lymphoma DLBCL
Spatially decoding genotype associated epigenetic landscapes in human lymphoma FFPE tissues via epi Patho DBiT
Prognostic impact of specific IGHV rearrangements in younger untreated Mantle Cell Lymphoma patients is independent of p53 alterations and may be modified by ibrutinib based regimens Insights from the TRIANGLE trial within the MULTIPLY proj

Vimeo Vimeo
17